Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Myeloproliferative Disorder Drugs

Out of stock

Price data last checked 48 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 48 days. Could come back at any time — we're watching for you.

Out of stock 48 days · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
01 May 2024

Similar Products You Might Like

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China
99% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in China

£495.00 19 Jun 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
98% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India

£515.00 23 Jun 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
98% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States

£520.00 25 Jun 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs for US Zip Codes
98% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs for US Zip Codes

£490.00 24 Jun 2026
The 2025-2030 World Outlook for Blood-Product Hematology Drugs
95% match

The 2025-2030 World Outlook for Blood-Product Hematology Drugs

Price unavailable
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
95% match

The 2023-2028 Outlook for Erythropoietin Drugs in the United States

£520.00 25 Jun 2026
The 2023-2028 Outlook for Erythropoietin Drugs in India
95% match

The 2023-2028 Outlook for Erythropoietin Drugs in India

£515.00 10 Jun 2026
The 2025-2030 World Outlook for Pre-Owned Medical Devices
95% match

The 2025-2030 World Outlook for Pre-Owned Medical Devices

Price unavailable
The 2025-2030 World Outlook for Advanced Therapy Medicinal Products
95% match

The 2025-2030 World Outlook for Advanced Therapy Medicinal Products

Price unavailable
The 2025-2030 World Outlook for Precision Medicines
95% match

The 2025-2030 World Outlook for Precision Medicines

Price unavailable
The 2016-2021 Outlook for Erythropoietins in the United States
95% match

The 2016-2021 Outlook for Erythropoietins in the United States

£595.00 24 Jun 2026
The 2025-2030 World Outlook for On-Premise Medical Document Management Systems
95% match

The 2025-2030 World Outlook for On-Premise Medical Document Management Systems

Price unavailable
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
95% match

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

£325.00 26 Jun 2026
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
95% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 12 Jun 2026
The 2025-2030 World Outlook for Rare Disease Drugs
95% match

The 2025-2030 World Outlook for Rare Disease Drugs

Price unavailable
The 2025-2030 World Outlook for Medical Document Management Systems
95% match

The 2025-2030 World Outlook for Medical Document Management Systems

Price unavailable
The 2025-2030 World Outlook for 3D Printed Drugs
95% match

The 2025-2030 World Outlook for 3D Printed Drugs

Price unavailable
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
95% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 18 Jun 2026
The 2016-2021 Outlook for Erythropoietins in Greater China
95% match

The 2016-2021 Outlook for Erythropoietins in Greater China

£595.00 20 Jun 2026
The 2025-2030 World Outlook for Dried Blood Spot Collection Cards
95% match

The 2025-2030 World Outlook for Dried Blood Spot Collection Cards

Price unavailable
The 2023-2028 World Outlook for Hematologic Malignancies
95% match

The 2023-2028 World Outlook for Hematologic Malignancies

Price unavailable
The 2025-2030 World Outlook for Customer Master Data Management
95% match

The 2025-2030 World Outlook for Customer Master Data Management

Price unavailable
The 2025-2030 World Outlook for Prefilled Syringes Drug Molecules
95% match

The 2025-2030 World Outlook for Prefilled Syringes Drug Molecules

Price unavailable
The 2023-2028 Outlook for Erythropoietin Drugs in China
95% match

The 2023-2028 Outlook for Erythropoietin Drugs in China

£495.00 23 Jun 2026